T1	Entity 123 150	Terminal duct lobular units
T8	SNP 1175 1183	rs616488
T9	SNP 1193 1203	rs11242675
T10	SNP 1216 1225	rs6001930
T11	Entity 1185 1190	PEX14
T12	Entity 1205 1210	FOXQ1
T13	Entity 1227 1231	MKL1
T14	Entity 1254 1271	higher TDLU count
R5	SNP_coupled_gene Arg1:T8 Arg2:T11	
R6	SNP_coupled_gene Arg1:T9 Arg2:T12	
R7	SNP_coupled_gene Arg1:T10 Arg2:T13	
T15	SNP 1316 1325	rs1353747
T16	Entity 1327 1332	PDE4D
T17	SNP 1338 1347	rs6472903
T18	Entity 1349 1356	8q21.11
R11	SNP_location Arg1:T17 Arg2:T18	
R12	SNP_coupled_gene Arg1:T15 Arg2:T16	
T21	SNP 1448 1457	rs1353747
T22	SNP 1470 1478	rs204247
T23	Entity 1459 1464	PDE4D
T24	Entity 1480 1486	RANBP9
R16	SNP_coupled_gene Arg1:T21 Arg2:T23	
R17	SNP_coupled_gene Arg1:T22 Arg2:T24	
T26	Entity 541 546	women
T27	Association 584 595	established
E1	Association:T27 
T28	Cancer 596 609	breast cancer
R21	Equiv Arg1:T28 Arg2:E1	
T29	Cell_types_tissues_affected 490 500	involution
E2	Cell_types_tissues_affected:T29 Agent:T31 Theme:T30
T30	Entity 485 489	TDLU
T31	SNP 420 424	SNPs
T32	Association 372 386	susceptibility
E3	Association:T32 bc:T33 snp_int:T31
T33	Cancer 358 371	breast cancer
T34	Spec 452 479	whether they are associated
R22	Speculation_marker Arg1:E2 Arg2:T34	
T37	Spec 568 580	investigated
T39	SNP 581 583;610 614	62 SNPs
R26	Population_assignment Arg1:T39 Arg2:T26	
T41	Entity 638 642	TDLU
T42	Cell_types_tissues_affected 643 653	involution
E6	Cell_types_tissues_affected:T42 Theme:T41 Agent:T39
T43	Level 1049 1078	not statistically significant
T44	SNP 980 987	36 SNPs
T45	SNP 983 987;989 994	SNPs 58.1%
R27	Equiv Arg1:T44 Arg2:T45	
T46	Cell_types_tissues_affected 1001 1008	related
E7	Cell_types_tissues_affected:T46 Theme:T48 Agent:T45
A1	Effect_Type E7 Increase
A2	Level E7 Low
T47	Effect_Type 1012 1018;1024 1030	higher counts
T48	Entity 1019 1023	TDLU
R28	Effect_type_marker Arg1:E7 Arg2:T47	
R29	Level_marker Arg1:E7 Arg2:T43	
T50	Cell_types_tissues_affected 1238 1248	associated
E8	Cell_types_tissues_affected:T50 Theme:T14 Agent:T10 Agent2:T9 Agent3:T8
T51	Cell_types_tissues_affected 1122 1142	nominally associated
E9	Cell_types_tissues_affected:T51 
R9	Equiv Arg1:E9 Arg2:E8	
T52	Effect_Type 1254 1260;1266 1271	higher count
A3	Effect_Type E8 Increase
R10	Effect_type_marker Arg1:E8 Arg2:T52	
R30	Risk_Factor Arg1:T8 Arg2:T14	
R31	Risk_Factor Arg1:T9 Arg2:T14	
R32	Risk_Factor Arg1:T10 Arg2:T14	
T53	Effect_Type 1379 1385;1392 1406	higher count per TDLU
T54	Cell_types_tissues_affected 1363 1373	associated
E10	Cell_types_tissues_affected:T54 Theme:T55 Agent:T17 Agent2:T15
A4	Effect_Type E10 Increase
R33	Effect_type_marker Arg1:E10 Arg2:T53	
T55	Entity 1386 1391	acini
T19	Entity 1379 1406	higher acini count per TDLU
R34	Risk_Factor Arg1:T17 Arg2:T19	
R35	Risk_Factor Arg1:T15 Arg2:T19	
T56	Cell_types_tissues_affected 1493 1503	associated
E11	Cell_types_tissues_affected:T56 Theme:T57 Theme2:T58 Agent:T21 Agent2:T22
T57	Entity 1524 1528	TDLU
T58	Entity 1533 1538	acini
T59	Effect_Type 1513 1523;1539 1545	product of counts
R36	Effect_type_marker Arg1:E11 Arg2:T59	
A5	Effect_Type E11 Increase
T61	SNP 1604 1622	breast cancer SNPs
T62	Spec 1623 1626	may
T63	Level 1627 1639	not strongly
T64	Cell_types_tissues_affected 1655 1665	involution
E12	Cell_types_tissues_affected:T64 Theme:T65 Agent:T61
T65	Entity 1650 1654	TDLU
A6	Level E12 Low
R38	Level_marker Arg1:E12 Arg2:T63	
R13	Speculation_marker Arg1:E6 Arg2:T37	
R23	Speculation_marker Arg1:E12 Arg2:T62	
R1	Equiv Arg1:T30 Arg2:T1	
